Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.5900
-0.0460 (-7.23%)
Nov 4, 2025, 4:00 PM EST
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of $635.09 million as of November 5, 2025. Its market cap has increased by 510.29% in one year.
Market Cap
635.09M
Enterprise Value
699.00M
Revenue
122.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.59
Market Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 296.29M to 635.09M, an increase of 114.35%. That is a compound annual growth rate of 12.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 635.09M | 207.35% |
| Dec 31, 2024 | 206.63M | 498.26% |
| Dec 29, 2023 | 34.54M | 69.69% |
| Dec 30, 2022 | 20.35M | -90.69% |
| Dec 31, 2021 | 218.67M | 51.51% |
| Dec 31, 2020 | 144.33M | 59.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |